Fariba Goodarzian, MD

Clinical Professor of Radiology (Clinician Educator)

Department Head of Radiology and Radiologist in - Chief, at CHLA

Image of Fariba Goodarzian, MD
Is this your profile? Click to edit

Publications

  • Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. J Clin Oncol. 2025 08; 43(22):2490-2501.. View in PubMed
  • Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nat Med. 2023 05; 29(5):1092-1102.. View in PubMed
  • Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. J Clin Oncol. 2021 11 01; 39(31):3506-3514.. View in PubMed
  • Absence of Testicular Adrenal Rest Tumors in Newborns, Infants, and Toddlers with Classical Congenital Adrenal Hyperplasia. Horm Res Paediatr. 2019; 92(3):157-161.. View in PubMed
  • Ensuring Appropriateness of Pediatric Second Opinion Consultations. Curr Probl Diagn Radiol. 2020 Mar – Apr; 49(2):82-84.. View in PubMed
  • Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2018 12 15; 24(24):6142-6149.. View in PubMed
  • The Utility of Cranial Ultrasound for Detection of Intracranial Hemorrhage in Infants. Pediatr Emerg Care. 2018 Feb; 34(2):96-101.. View in PubMed
  • Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma. Pediatr Blood Cancer. 2018 05; 65(5):e26940.. View in PubMed
  • Improving Pediatric Breast Ultrasound Reporting and Recommendations. J Am Coll Radiol. 2017 11; 14(11):1451-1454.. View in PubMed
  • Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clin Cancer Res. 2017 Sep 15; 23(18):5374-5383.. View in PubMed